1.Neuroimmunology Laboratory at the Multiple Sclerosis Center, Sheba Medical Center, Laura Schwarz-Kipp Research of Autoimmune Diseases, Sackler School of Medicine Tel-Aviv University, Ramat-Gann, Israel ;
Abstract:
Journal of Neurology - The majority of multiple sclerosis [MS] patients treated with fingolimod fail to develop a protective level of IgG humoral and adaptive cellular immune responses following...